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HERPESVIRUSES AND ONCOGENESIS 
I. Epidemiological and I_n \M _\^o Evidence. 
The concept that herpesviruses are intimately asso¬ 
ciated with, if not indeed etiologic agents of, some forms 
of human cancer is scarcely two decades old. The demon¬ 
stration in 1964 by Epstein et a 1 . that a herpesvirus 
could be found in cultured lymphoblasts of African Burkitt 
lymphoma was highly suggestive. 
Work with the Lucke carcinoma of the frog earlier 
established the presence of herpesvirus particles in the 
2 
tumor cells , but it was not until 1969 that Mizell et al. 
were able to induce tumors i_n vitro in frog tissue using 
3 
the Lucke virus. This work was later confirmed g_n vivo 
4 
by Naegle et a 1. 
Similarly, Marek's tumor of chickens, long known to 
be a contagious lymphoma, was found to harbor a herpesvirus 
5 
in 1967. The discovery that immunizing chickens with a 
related herpesvirus of turkeys (1970) could prevent tumor 
6 
formation added compelling evidence that herpesviruses 
may be oncogenic in animals. Efforts to develop more 
direct associations for herpesviruses and malignancies 
in mamma Is ensued. 
In primates, studies established that Herpes saimiri, 
a non-pathogenic herpesvirus in its natural squirrel monkey 

2 
host, induced lymphomas in owl monkeys and cottontop mar- 
7 8 
mosets and fatal leukemias in other sub-human primates. 
In 1972, another simian herpesvirus. Herpes ateles, was 
7 9 
shown to be oncogenic in South American monkeys. ’ These 
investigations have not only provided considerable evidence 
of herpesvirus oncogenicity in primates but also supported 
4 
a concept which evolved from the Lucke virus studies: 
that a latent, benign viral infection in one setting might 
result in malignant tumor formation in another. 
Efforts to demonstrate oncogenesis by human herpes¬ 
viruses have been nearly as fruitful. Epidemiological 
association of Epstein-Barr virus (EBV) with Burkitt's 
lymphoma was provided by Henle's report of the correlation 
of high EBV antibody titers in lymphoma patients; geomet¬ 
ric mean titer in the tumor patients was 275 while control 
patients' titers averaged 37.^ Subsequently, EB virus 
was cultured from many lymphoblastoid cell lines derived 
1112 12 
from Burkitt lymphoma tissue; ’ EBV antigens and EBV 
specific DNA sequences were identified^-^ in the nuclei 
of Burkitt lymphoma cells. Similar antigenic associations 
1819 1920 
’ and nucleic acid homologies ’ have been described 
in the tissues of nasopharyngeal carcinoma. 
More direct evidence of oncogenicity was obtained by 
inoculation of EBV into sub-human primates. Malignant 
lymphomas produced by EBV in cottontop marmosets and owl 
22 23 
monkeys ’ yielded E B V-prod uc i n g cell lines i_n vitro; 

3 
24 2 5 
and EB nuclear antigen and EBV genomes were detected 
in the primary tumor cells as well. 
Implicating other herpesviruses in human malignancy 
has been less rewarding. To date, there is no i_n vivo 
evidence linking cytomegalovirus (CMV) or varicella zoster 
2 6 2 7 
virus (VZV) with oncogenesis although Albrecht et a 1 . 
induced i_n vitro malignant t ra n s f o rma t i on of hamster cells 
with u11ravio1et-irradia ted CMV. Studies with Herpes 
simplex virus (HSV) have been more suggestive, and are 
. , , , . , 26,28-30 
recently well reviewed. 
31 
Naib first suggested the association of HSV type 2 
with cancer of the uterine cervix. Nahmias et a 1. found 
that the incidence of cervical dysplasia and i_n situ carcin¬ 
oma was increased 2 to 8-fold among HSV type 2 seropositive 
32 
individuals compared to seronegative controls, strength¬ 
ening Gagnon's observation some fifteen years earlier that 
not a single case of cancer of the cervix was found among 
3 3 
13,000 Catholic nuns over a 20 year survey period. 
Attempts to identify HSV-2 specific antigens in 
34 
cervical tumor tissue have been generally unsuccessful. 
Aurelian was able to detect immunity to an HSV-2-induced 
tumor-specific antigen in cervical cancer patients while 
3 5 
no such antibody was found among controls. Several in¬ 
vestigators reported finding HSV antigens in 2-20% of ex¬ 
foliated cells in 60% of Papanicolau smears of patients 
O A Q £ 
with invasive cancer, versus 0-6% in control smears. ’ 

4 
Evidence documenting HSV DNA in tumor cells has been 
o 7 o o 
contradictory, 5 although Frenkel et al. detected a 
fragment of Herpes simplex type 2 DNA in the cells of a 
cervical carcinoma; Aurelian et al. (1971) reported 
recovery of HSV-2 from cervical tumor cells in tissue cul¬ 
ture^ and complete virus particles were observed in cells 
41 
of 2 of 14 cervical tumors by Herrera et al. 
Compared to the weight of data supporting the role 
of EBV in oncogenesis, the evidence relating HSV to human 
cervical cancer is highly suggestive, but by no means con- 
-i . 27,30 ,42 
elusive. 
II. Herpesvirus Infection: Lytic and Latent Mechanisms. 
Interpretation of the epidemiological and biological 
associations of herpesviruses and malignancy depends on 
understanding the dynamics of cell-virus interaction during 
infection. For example, a high proportion of individuals 
with cervical cancer have serological and histologic history 
of HSV-2 infection, yet it is clear that oncogenic trans¬ 
formation of infected cells never occurs in the majority 
4 3 
of affected persons. Similarly, Epstein-Barr virus i n - 
_ 44 
fection is extremely prevalent world-wide but only a tiny 
fraction can be associated with Burkitt's lymphoma or naso- 
4 5 
pharyngeal carcinoma. Is there, then, more than one way 
in which the infecting virus influences the cell? 

5 
It is likely that all herpesviruses are capable of 
4 6 4 7 
establishing both lytic and latent infections and 
that the specific mode of infection depends to a consid¬ 
erable degree on the native characteristics of the host 
cell. In the case of Epstein-Barr virus, human umbilical 
cord lymphocytes transformed by EBV into cell lines with 
the ability to grow continuously in culture produce no 
detectable virus despite the presence of EB nuclear anti- 
4 8 
gen (EBNA) and EBV DNA in the transformants. A non-pro¬ 
ductive lymphoblastoid line (Raji) with similar character- 
49 
istics has been isolated from Burkitt lymphoma. Infec¬ 
tion of marmoset lymphocytes with the same strain ofnEBV 
results in transformation and considerable virus production 
Epithelial cells are characteristically permissive 
for the replication of Herpes simplex virus: the outcome 
is cell lysis and death. ^>46 other cells, e.g. those of 
neural origin, appear to be non-permissive for replication 
4 9 
and the usual outcome of HSV infection is 1 atency. 
4 7 5 0 
Stevens has summarized the data on this point. 5 
Intact virus and hybridizable DNA sequences of latent HSV 
have been demonstrated in trigeminal ganglion neurons after 
51 
experimental chronic herpetic eye infection in rabbits 
52 
and mice; reactivation of dormant infection has been 
5 3 5 0 
achieved by neurectomy or imposition of septic shock. 
54 
Baringer documented recovery of infectious HSV-1 from 31 
48 
of 71 human cadaver trigeminal ganglia examined, and HSV-2 

6 
from 5 of 46 sacral ganglia, suggesting that 50% of the 
human population may harbor latent HSV in their sensory 
, • 55,56 
ganglia. 
The ability of HSV to establish latent infection 
in human cells is now wel1-documented but it is less cer¬ 
tain whether HSV may be capable of oncogenic transformation 
in human disease. The demonstration of HSV DNA and HSV 
antigens in cervical carcinoma tissue has bolstered spec¬ 
ulation that HSV may also be a "transforming virus" in 
5 7 
the production of human cervical cancer. Attempts to 
support this thesis with i_n vitro techniques are discussed 
below. 
III. Oncogenicity and Herpesviruses: ^n Vitro Evidence. 
Insights from i_n vivo and epidemiological studies 
led to experiments combining cells and herpesviruses in 
vitro with hopes of inducing oncogenic transformation under 
controlled circumstances. 
A. Transformation by Epstein-Barr Virus. 
1 1 
The first report by Henle et al. in 1967 of trans¬ 
formation by EBV of human leukocytes co-cultivated with 
X-irradiated cells from a Burkitt's lymphoma tumor was 
followed shortly by Pope et al. (1968) who transformed 

7 
fetal leukocytes using the filtered extracts of an EBV- 
1 2 
producing leukemia cell line. This work was confirmed 
SR 
by Miller et al. in 1969. 
In these and the numerous subsequent reports, the 
i n vitro transformation of leukocytes by EBV exhibits the 
following characteristics: 
1) EBV from several sources produces transformation, 
11 12 
including Burkitt cells, leukemia, infectious mono- 
59 48 
nucleosis and previously transformed monkey leukocytes. 
6 0 
2) a single target cel 1--probably a "B" lymphocyte -- 
can be derived from several sources, including fetal bone 
61 5 2 
marrow , umbilical cord blood and peripheral adult 
blood.58 
3) morphologically and biologically, the transformed 
cells are lymphoblasts which are capable of surviving 
and dividing continuously in culture. 
4) the EBV DNA is associated with the host cell's 
genome and can be detected by the presence of viral antigens 
(EBNA)1 3 and hybridizable DNA sequences."*^ 
Certain aspects of the i_n vitro EBV transformed 
cell are strikingly similar to those of the Burkitt lymphoma 
cell, i.e. the presence of EBV DNA and antigens in lymphoid 
cells with altered growth characteristics. On the strength 
of these similarities, the EBV model of oncogenesis is a 
convenient standard by which other "transformation" systems 
can be measured. 

8 
B. Transformation by Herpes Simplex Virus. 
Efforts to induce i_n vitro transformati on by other 
human herpesviruses are in general frustrated by the ten- 
dancy of the virus to undergo lytic infection in the host, 
64 
resulting in cell death before transformation. A number 
of experimental techniques have been brought to bear on 
this problem: 
1) development of temperature-sensitive mutant viruses 
(Ts) which are infectious at physiological (permissive) 
temperatures but able to infect cells without lytic repro- 
6 5-69 
duction at elevated (non-permissive) temperatures. 
2) partial inactivation of virus by pre-treatment 
with sub-lethal doses of ultraviolet (UV) 1ight ^70-72 
7376 7277 
chemicals7 or light-activated chemicals. ’ 
3) suppression of viral reproduction after infection 
by maintaining infected cell cultures at elevated temper- 
atures . ^ 
4) use of specific viral DNA fragments defective 
for lytic functions to "transfect" cells directiy.^ 
The thesis behind these maneuvers is that if a portion 
of the herpesvirus genome which directs viral reproduction 
and cell lysis can be suppressed, deleted or bypassed, 
O I 
oncogenic functions of the virus may be unmasked. 
Owing to the lytic behavior of HSV in epithelial 
tissues, transformation attempts were begun with partially- 

9 
inactivated virus, using a variety of non-lymphoid cell 
types as targets. These studies are summarized in Table I. 
Using ultraviolet-irradiated HSV, in which infectivity 
had been reduced by 10 Duff and Rapp^’82»83 were able 
_ 5 
to transform hamster embryo cells at a frequency of 10 
transformants per normal cell. The transformants had the 
following properties: 
1) transformation was observed with a minority of 
virus strains tested (2 of 12);^ 
2) transformants grew out into stable tissue culture 
, , -] • 38,68,72,84,85 
cel 1 1 i nes; ’ * ’ 
38 86 
3) transformed lines expressed HSV surface antigens; ’ 
4) transformed cells induced tumors in Syrian hamsters 
, .. 38,68,82 
on l nocula11on; 
5) transformants were morpho 1ogica11y poorly differ- 
. . . , 80,82 
en 11 a ted. 
It should be noted that the transformed lines yielded no 
infectious virus or cytopathic effect in culture with sus¬ 
ceptible cells. 
HSV DNA fragments in these transformants have been 
8 7 o o 
reported to represent 10% and 8-32% of the genome, 
3 7 
although Summers could find no sequences in seven strains 
of HSV-transformed cell lines. Morphological and tumori- 
genic transformation of rodent cells was also achieved 
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HSV.73 ’ 78,89 
Biochemical transformation, in which the transfor¬ 
mants are morphologically unchanged but exhibit altered 
enzymatic characteristics , has been accomplished with HSV 
in mouse "L" cells. Culturing infected cells in medium 
8 5 
lethal for the absence of thymidine kinase activity 
selects transformants possessing this enzyme (TK+) while 
uninfected or untransformed cells lacking the enzyme (TK ) 
do not survive. Biochemical transformation of rodent 
cells lacking thymidine kinase was induced with ultraviolet- 
irradiated HSV (UV-HSV),^ with live HSV in non-permissive 
90 
Rous-sarcoma transformed rat cells and more recently 
O Q 
with specific HSV DNA fragments alone. In subsequent 
work, hybridization techniques have detected 6 copies of 
HSV DNA fragments representing 15% of the viral genome 
in the TK+ transformed cells, with none reported in the 
91 
TK cells. The newly induced enzyme is considered to be 
of viral origin, in that the transformed cell enzyme's sub¬ 
strate specificity and electrophoretic mobility are identi¬ 
cal to the native HSV enzyme. 
IV. Interaction of Lymphoid Cells and Herpes Simplex Virus. 
Interest in transforming lymphoid cells with HSV grew 
out of the experience with EBV, although iji vivo evidence 
that HSV infects lymphocytes latently or lytically is lacking. 

A. Replication. 
Experiments demonstrating the extent to which HSV 
can infect and replicate in lymphoid cells are summarized 
in Table II. i It will be readily recognized that in contrast 
to epithelial tissues, primary unstimulated lymphocytes 
89 95-97 
support HSV replication very poorly. * However, 
lymphocytes stimulated with mitogens (phytohemaglutinin 
(PHA), concanavalin A (Con A), anti 1ymphocyte globulin) 
support HSV replication over a short (2 to 5 day) period 
before the lytic effects of the virus presumably kill the 
95 96-99 
culture. * The virus reportedly grows well in both 
97 99 1DD 
T and B lymphocyte cell lines ’ 5 and the initial 
belief that only T cells replicate virus'^"* appears now 
97 99 
to be unfounded. ’ 
Why lymphocytes are especially resistant to productive 
infection by HSV is not clear. The fact that cells actively 
synthesizing DNA (mitogen stimulated or cell lines) support 
replication much more readily suggests that the state of 
9 6 
cellular metabolism may play an important part. Of interest 
9 5 
is the report by Daniels et al. of HSV replication in 
human macrophages j_n vitro. Attempts to infect freshly 
isolated macrophages resulted only in "abortive infection" 
in which no infectious virus was produced but empty viral 
capsids and HSV antigens were detected in the cells. In 
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but in cultures aged" iji vitro for 3 days, susceptible 
cells increased to 1% and rising viral titer was noted 
over the next four days. Confirmation of this work or 
elucidation of the fate of the abortively infected cells 
has not been reported. 
B. Antigenic Stimulation. 
Efforts to induce transformed lymphocyte cell lines 
with HSV have been unsuccessful to date, but several inves¬ 
tigators have succeeded in transient stimulation of lympho¬ 
cytes p re - i mmun i zed to HSV i_n vivo. These experiments are 
summarized in Table III. 
Rosenberg's work"*^ with lymphocytes of HSV-immune 
rabbits documented that significant stimulation (evidenced 
3 
by increased uptake of tritiated thymidine ( HTdr)), occurred 
3 days after infection with HSV, an effect which was increased 
by UV treatment of the virus. The stimulation was transitory 
(3 to 5 days) and was associated with increased synthesis 
of cellular, not viral DN A . ^ No stimulation occurred 
in cells from antibody negative animals. 
Similar results were achieved with both live and 
inactivated HSV in lymphocytes of immune human donors.^ ^» 
Corey et al., and Lopez et al. have studied 
the stimulation of lymphocytes from persons with active or 
recurrent herpes labiahis infection by UV irradiated HSV in 

some detail. They found stimulation indices ( = ratio 
3 
of HTdr uptake by HSV-infected lymphocytes compared with 
the uptake by uninfected controls) as high as 69 in patients 
with symptomatic herpes infection. The magnitude of lympho¬ 
cyte stimulation correlated with the stage of virus infection 
the peak of lymphocyte stimulation index was observed to 
coincide with the maximal rate of virus shedding. ^ Stim¬ 
ulation decreased to lower levels in convalescent, but anti¬ 
body positive individuals.^ 
Corey observed that cells from neutralizing-antibody 
negative donors produced stimulation indices of 0.8 + 0.2. 
109 113 
This finding was confirmed by Starr and Rasmussen 
7 5 7 6 
and by Shillitoe et al. * who also noted that two sero¬ 
negative control patients whose stimulation index was unex¬ 
pectedly greater than 2.0, developed active vesicular disease 
and seroconversion within two weeks. 
The latter observation may help explain the divergent 
finding by Lopez et al."*^ of an average stimulation index 
of 4.5 in 11 asymptomatic, seronegative controls but never¬ 
theless, this result is clearly at odds with those of the 
other studies cited. 
The bulk of the data suggest, then, that UV-irradiated 
HSV is antigenic to lymphocytes in immune humans and rabbits 
but the resulting stimulation is transitory and probably 
linked to a cellular immune response to antigens on the 
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creased HTdr uptake is due to increased cellular, not 
viral DNA synthesis, as evidenced by cesium chloride gradient 
DNA analysis^'7 and the finding that live HSV infected 
cultures do not exhibit increased thymidine uptake despite 
ongoing viral synthesis. ^ 
C. Mitogenic Stimulation. 
Mitogenic stimulation is distinguished from antigenic 
stimulation by the ability of the mitogen to cause stim¬ 
ulation of both immune and non-immune cells, whereas antigens 
11 4 
stimulate only pre-immunized cells. Demonstration of 
stimulation of non-immune lymphocytes by HSV would be a 
first step toward the goal of oncogenic transformation. 
Studies of non-immune lymphocytes and HSV have been 
few. Review of the experiments cited in Table III shows 
that stimulation of lymphocytes from HSV-antibody negative 
humans is generally unsuccessful. In the cases where 
stimulation was reported,interpretation is confounded 
by the possibility of cross-reaction of lymphocytes immun¬ 
ized to related antigens. 
Experiments with lymphocytes derived from the spleens 
of nude mice conducted in separate laboratories^ 5,116 ^ave 
documented that live HSV is strongly mitogenic in mice 
(Table IV). Moreover, the stimulation is maximized in 

























































































































inactivation of the virus. Only a minority of the virus 
116 
strains tested possessed stimulatory activity, however. 
These results are in contrast to the "antigen" stim¬ 
ulation studies cited in Table III: the effect requires 
live virus, and maximal stimulation occurs at 3 days versus 
7 days in the antigen studies. 
Investigation of lymphocyte response to HSV in immune- 
deficient/compromised individuals has not been reported 
but one experiment involving heat-inactivated HSV and human 
1 09 
umbilical cord lymphocytes found no stimulation. 
V. Modes of Latent Infection and Transformation. 
Transformation of cells by both Epstein-Barr virus 
and Herpes simplex virus is well-documented, although the 
inability to recover infectious virus from any HSV trans- 
8 2 
formants and to demonstrate viral genome sequences in 
3 8 
all HSV-induced cell lines attests to clear differences 
between HSV-induced and EBV-induced transformation. When 
detectable, HSV DNA in transformed cell lines is only a 
small fragment, in contrast to the multiple copies of com¬ 
plete genomes found in EBV lymphoblastoid lines. Intact 
EBV transforms cells but HSV must be partially inactivated 
to perform this function. The striking 'similarity in the 
UV doses used to achieve maximum transforming efficiency 

2 
(10-15,000 ergs/mm -sec) for both tumorigenic and biochem¬ 
ical transformation may be indicative of the target sizes 
of the "lytic" and "transforming" parts of the HSV genome, 
but no such differentiation of functions has been clearly 
demonstrated in EBV. 
Regarding the setting in which latent herpesvirus 
infection may occur, four prominent possibilities have 
been proposed: 
1) viral genome is present in cells but unexpressed; 
it is capable of reactivation into a lytic, productive 
4 7 5 3 
cycle, 5 e.g. recurrent herpes labial is, h. progenita1is , 
h. zoster. 
2) viral genome, or part of it, is present and 
expressed as oncogenic trans forma tion of the host cell, 
with malignancy as the outcome; lytic functions of the 
16 17 
genome are either missing or suppressed 5 e.g. EBV in 
Burkitt lymphoma, Marek's virus and chicken lymphoma. 
3) viral genome is present during the initial trans¬ 
formation of the cell, but continued presence of the genome 
is not required for ongoing reproduction of the transfor¬ 
mant progeny e.g. the so-called "hit and run" model of 
. 92 
careinogenesls. 
4) viral genome or fragment is present in the infected 
cell as the inducer/promotor of a latent C-type RNA virus 
93 94 
which in turn transforms the cell. ’ The studies cited 
in Table I provide support for each of the first three 

1 7 
proposals although the evidence is inconclusive for all. 
The last possiblity, that of oncornavirus activation, was 
94 
suggested by the finding of Hampar et al. that infection 
of rodent cells with UV-HSV resulted in the induction of 
9 3 
a xenotropic C-type virus. Kraiselburd et al. extended 
these observations by noting that the optimum UV dose for 
xenotropic virus induction closely parallelled that for 
maximum thymidine kinase transformation and proposing that 
the genes of HSV causing this effect represent a small 
fraction of the genome. HSV DNA synthesis was not required 
93 
for activation of the C-type virus. 
Although it may be helpful to conceptualize trans¬ 
formation by herpesviruses occurring in latent infection 
as occurring by one or more of the mechanisms cited above, 
it is not at all clear which, if any, of these is pertinent 
to transformation by Herpes simplex virus. Further studies 
are required to elucidate the details of HSV transformation. 
VI. Rationale for Experiments with Herpes Simplex Virus 
and Non-Immune Lymphocytes. 
The purpose of the experiments presented in this 
paper was to investigate the possiblity that primary lympho¬ 
cytes could be stimulated or transformed by UV-irradia ted 
HSV. 
Choice of the lymphocyte was based on several consid- 

erations. First, lymphocytes had been shown to be rela- 
96-99 109 
tively non-permissive for HSV replication. ’ Success¬ 
ful stimulation and transformation experiments in the past 
have been conducted in non-permissive cells (cf. umbilical 
6 2 
cord lymphocyte with EBV and the mouse spleen lympho¬ 
cyte and HSV^^’^6). Further, the existence of lympho- 
blastoid cell lines derived from cancer patients in which 
no virus can be identified suggested that perhaps HSV could 
be a "transforming virus" for lymphocytes. Use of non- 
immune, washed lymphocytes collected from umbilical cord 
blood at the time of fetal delivery would minimize confu¬ 
sion about lymphocyte-antigen cross reaction or mitogenesis 
11 4 
associated with antigen-antibody complexes. 
Similarly, partial inactivation of the virus was 
considered likely to maximize stimulatory properties of 
the virus since lymphocytes had been shown to support 
limited replication of HSV over the time period in which 
stimulation was expected to be evident (3 to 7 days).^^ 
Choice of ultraviolet irradiation was based on the docu¬ 
mented ability of UV-irradia ted HSV to transform rodent 
38 4 0 
cells, ’ and in accordance with the hypothesis that 
the lytic functions of the HSV genome have a larger UV 
70 82 
target size than the transforming functions. ’ 
Assays for stimulation of DNA synthesis, manifested 
by the level of thymidine uptake, determinations of the 

infectivity of live and inactivated virus, and 
to induce transformation of cells in different 
attempts 
conditions 
of tissue culture were conducted. 

20 
MATERIALS AND METHODS 
Virus. HSV type 1, strain No. 15077, was derived from a 
brain specimen obtained from a patient with encephalitis. 
It was isolated in the Vero line of African Green Monkey 
cells and subsequently passaged three times in the AH-1 
Green Monkey Kidney (GMK) cell line. The virus stock titer 
was 5 X 10 plaque-forming units (pfu)/0.1 ml in Vero cells. 
Prior to use the virus was passaged once more in 
GMK AH-1 cells at a multiplicity of infection of 1 pfu/cell. 
After three or four days, the supernatant fluid was collected 
and the cellular debris removed by low-speed centrifugation. 
The titer of this stock, designated "unpurified virus" 
was 10^ pfu/0.1 ml . 
"Purified virus" was subjected to the following 
further processing: the supernatant was centrifuged in 
a Beckman Type 19 rotor for 3 hours at 5°C, 20,000 rpm; 
the pellet was resuspended in 1 ml of Tris .05M and NaCl 
.15M buffer, layered on a 20-60% continuous sucrose gra¬ 
dient and centrifuged in an SW 27 rotor at 23,000 rpm for 
90 minutes. A discrete, light-scattering band was collected 
and dialyzed against RPMI 1640 medium for 48 hours at 5°C. 
The virus was divided into 1.0 ml aliquots and stored at 
o 9 
-70 C until use. "Purified virus" stock titer was 10 pfu 
48 
per 0.1 ml. By electron microscopy this stock consisted 

21 
of 82% enveloped virus particles, 18% capsids, and contained 
no cellular debris. All virus stocks were shown to be free 
of mycoplasma by culturing on mycoplasma agar. 
UV Irradiation of Virus . Virus suspensions in growth 
medium (2 ml) were irradiated in 6 cm plastic culture 
dishes with a 25 watt GE Germicidal Lamp at a distance of 
12 cm. Irradiation at this distance produced an ultra- 
2 
violet light intensity of 25 ergs/mm -sec as determined 
by a dosimeter constructed and calibrated by R. Latarjet,^7 
and kindly loaned by D. Rupp. During irradiation the 
dishes were kept on ice and rotated 100 revolutions per 
minute on a rotary platform shaker, while exposed to atmos¬ 
pheric oxygen. 
Plaque Titration of Virus. Stock and UV-treated virus 
(0.1 ml), at various dilutions in growth medium, were inoc¬ 
ulated onto confluent monolayers of GMK AH-1 cells in 6 cm 
plastic culture dishes. After one hour, 3 ml of 1.5% 
methyl cel 1ulose in growth medium was added and the dishes 
were incubated at 37°C in 5% CO2 in air. After 3 days, 
the dishes were drained, fixed in absolute methanol for 
5 minutes and stained by the method of Giemsa. Charac¬ 
teristic plaques were counted and titer was expressed as 
plaque-forming units per 0.1 ml. 

22 
Cell Isolation. Human umbilical cord leukocytes (HUCL) 
118 
derived by the Ficol 1-Hypaque method were used. 
To obtain cell populations depleted of T lymphocytes, 
mononuclear cells (5-10 X 10 leukocytes) were mixed with 
a 1% suspension of sheep erythrocytes pre-treated with 
25 units/ml of neuraminidase (Vibrio cholerae, Calbiochem), 
centrifuged for 10 minutes at 200 £ and held at room tem- 
1 1 9 
perature for one hour. The resulting mixture of rosetting 
cells (E rosettes) and nonrosetting cells was then layered 
over a second Ficoll-Hypaque gradient and centrifuged for 
30 minutes at 400 £. The population at the interface then 
contained less than 5% of cells which formed E rosettes. 
This population,designated "B" enriched cells, was concentra- 
r 
ted to 4 X 10 cells / ml for thymidine assays. 
To obtain cell populations enriched for macrophages, 
freshly isolated human umbilical cord lymphocytes were 
suspended in growth medium and cultured flat in tissue culture 
flasks. Non-adherent cells were washed off three times 
during 7 days. The cells were harvested by washing in 
1 22 
calcium-free medium several times , assayed for purity 
by demonstration of phagocytosis of EAC-IgG reagent-treated 
1 2 3 
erythrocytes and infected as described above. These 
cells consisted of greater than 98% phagocytosing cells. 
Cell Cuil ture. Before exposure to virus, some leukocyte 
populations were maintained for 12-24 hours at 4X10^ cells 

23 
per ml in tissue culture flasks. This had the effect of 
removing most of the mononuclear phagocytic cells (popula- 
tion designated "macrophage depleted." ) Medium, RPMI 
1 640 , was supplemented with penicillin (50 U/ml) , strep¬ 
tomycin (50 ug/ml), amphotericin B (1 ug/ml) and various 
concentrations of heat-inactivated (56°C, 30 minutes) fetal 
calf serum. 0.1 ml aliquots of cells were placed in wells 
of microtiter plates (Costar) at 4 X1 0 ^ cells/ml. 0.1 ml 
virus or medium was added as inoculum. All cells were 
cultured at 37°C in an atmosphere of 5% CO^ and air. 
Cell Counts. At the end of the culture interval, 2-4 wells 
of cells from each infected and sham-infected group were 
pooled and assayed for viability (Trypan Blue exclusion) and 
cell number (Coulter Counter). 
Infectious Centers Assay. To determine the fraction of 
leukocytes in which viral replication occurred, varying 
numbers of infected cells were plated onto a monolayer of 
HSV-1 susceptible cells (GMK AH-1) : leukocytes in growth 
medium were inoculated with HSV at a multiplicity of 10:1 
pfu per cell; after one hour an equal volume of rabbit 
antiserum to HSV (titer 1:40, E. Grogan) was added; after 
an additional hour the cells were washed twice in Hank's 
Balanced Salt Solution (HBSS) and plated onto GMK cell 
monolayers. The plates were cultured for 3 days at 37°C 

24 
under a layer of 1.5% methy1 cel 1ulose, following which they 
were drained, fixed in absolute methanol and stained with 
Giemsa. Plaques were counted and the results expressed 
_ 3 
as infected cells/total cells plated X 10 
Lymphocyte Stimulation Assay. Incorporation of tritiated 
thymidine ( HTdr) into acid-insoluble material was measured 
in infected and sham-infected cultures during the last 
four hours of incubation by the addition of 0.1 ml of 
3 
HTdr (specific activity 6.7 Ci/mM) to each well. The final 
concentration was 5 uCi/ml. The reaction was stopped by 
placing the micro titer plate on ice for 20 minutes. 
Acid insoluble material was collected by pipetting 
the contents of each well onto a 2.5 cm membrane filter 
(Millipore Corp., type HA, 0.45 urn) and washing each well 
with a small volume of HBSS to which 1.0 ml of trichloro¬ 
acetic acid (w/vol) was added. The filters were then 
rinsed twice in 5 ml of water, dried and placed in vials 
with scintillation fluid (Econofluor, New England Nuclear). 
Radioactivity was determined in a liquid scintillation 
121 3 
counter. Separate experiments demonstrated that HTdr 
added to cells and collected on filters without incubation 
resulted in counts per minute less than 10% of the values 
from incubated cultures. 
Assays were done with 6 to 8 wells per group;average 
activity was expressed as the mean of counts per minute 

per well of each group and the standard error of the mean 
of these groups was consistently less than 10% of the mean 
Lymphocyte stimulation was expressed as "stimulation index 
i.e., the mean counts/minute of infected cultures divided 
by mean counts/minute of sham/infee ted cultures. Statis¬ 
tical significance of differences was determined by the 




Infected Centers Assay. Previous studies established 
that HSV replication in lymphocytes is a limited, trans- 
96-99 109 
ient phenomenon, * but the fraction of cells pro¬ 
ductively infected in culture has not been determined. 
This can be approximated by calculation of the fraction 
of lymphocytes exposed to HSV which will induce a charac¬ 
teristic plaque after incubation on a monolayer of per¬ 
missive cells such as GMK. 
Table V shows that fewer than 1/1000 freshly iso¬ 
lated umbilical cord lymphocytes will support lytic viral 
replication. However, if these cells are maintained in 
culture for more than 5 days, the number of susceptible 
cells increases almost ten-fold. 
To determine if one type of lymphocyte was more 
susceptible, populations enriched for "B" cells and macro¬ 
phages were prepared and assayed for infectious centers. 
As shown in Table V, the number of infectious centers formed 
by B-enriched cells and macrophages were not significantly 
different from the mixed cultures. Tritiated thymidine 
incorporation in parallel cultures of mixed umbilical cord 
lymphocytes increased almost two-fold after 7 days of i_n 
1 21 
vitro culture without virus. 
UV Inactivation of HSV-1. Results of titration of virus 
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subjected to UV irradiation are shown in Figure 1. It 
will be noted that infectivity is rapidly inactivated during 
the first minute of exposure but a relatively resistant 
region is encountered from 1 to 6 minutes; essentially 
complete inactivation is achieved by 20 minutes of expo¬ 
sure. These results are nearly identical to those obtained 
82 124 
by other investigators. ’ 
Stimulation of Umbilical Cord Lymphocytes by HSV. Pre1im- 
inary thymidine uptake assays revealed a small but sig¬ 
nificant stimulation of lymphocytes infected by HSV irra¬ 
diated for 6' to 10' (stimulation index = 1.15). This 
effect was apparent only on the third and fourth days of 
incubation. Increasing the multiplicity of infection from 
1:1 to 100:1 pfu/cell, the use of purified virus and en¬ 
riching the cells for B lymphocytes did not improve the 
stimulation achieved, although the effect was consistently 
observed in several experiments. 
A number of attempts by other investigators to demon¬ 
strate induction of cellular DNA synthesis by virus have 
been successful only when the cells were "metabo 1ica11y 
arrested." Yamanishi et al. demonstrated a five-fold 
stimulation of hamster cells exposed to a temperature-sens¬ 
itive mutant HSV only when the serum concentration was 
less than 1%. ^ Human embryo fibroblasts exhibited a 




in 0.2% fetal calf serum. St. Jeor et a 1. induced cellu¬ 
lar DNA synthesis with live CMV (stimulation index = 9) 
when human embryonic lung cells were incubated in 0.2% 
fetal calf serum, but not in higher concentrations of 
125 
serum. 
Umbilical cord lymphocytes maintained in culture 
medium supplemented with 20% fetal calf serum exhibit a 
3 
marked spontaneous increase in HTdr uptake during the first 
1 21 
7 days of culture. This increase in background activity 
in uninfected cells may mask transient stimulatory phen¬ 
omena which may be occurring simultaneously in the infected 
culture. Accordingly, stimulation assays were conducted 
in medium supplemented with 0.2% fetal calf serum; these 
are compared to parallel experiments in 20% fetal calf 
serum in Figure 3. 
Significant stimulation (p < .001) in the 0.2% serum 
cultures was observed on the fourth day of incubation for 
all UV-treated virus; the highest values occurred with 
6' and 10' UV doses (stimulation index = 1.7). Stimula¬ 
tion was significant (p < .001) in the 20% fetal calf serum 
cultures only for 10' UV-HSV infected cells, but the stim¬ 
ulation index was small ( = 1.11). Thymidine uptake in 
cells exposed to unirradiated HSV was significantly depressed 
below control cultures in both serum concentrations tested. 
Results similar to those of Figure 3 with mixed lym¬ 
phocytes were repeated in five consecutive umbilical cord 
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blood specimens (mean stimulation index + SEM = 1.58 + 
0.12). i 
Enrichment of lymphocytes for "B" cells significantly 
increased the stimulation index, as shown in Table VI. 
These cells had also been depleted of macrophages prior 
to inoculation. The values obtained for O', 6' irradia¬ 
ted UV-HSV were unchanged, but 10' UV-HSV resulted in a 
stimulation index of 2.02, compared with 1.67 in mixed 
cells (p < .001). 
Stimulation assays done on the seventh day after 
infection in 0.2% fetal calf serum resulted in a stimula¬ 
tion index (SI) of 1.43 (p <.001) for 10' UV-HSV and SI = 
1.08 (p = non-significant) for 6‘ UV-HSV. Uptake assays 
for periods longer than 7 days have not been conducted in 
0.2% fetal calf serum. Experiments with 20% serum at 
14 days showed thymidine uptake less than 50% of controls 
for all virus preparations tested (O',6',10'). Continued 
stimulation of lymphocytes in reduced-serum medium at 
7 days suggests that longer term activity of the UV-treated 
virus may be present. 
To help exclude the possibility that the producer 
cells (GMK) elaborate a soluble mitogen which was respon¬ 
sible for the observed stimulation, both purified and un¬ 
purified virus suspensions were centrifuged for 1 hour at 
23,000 rpm (SW 27 rotor), and the supernatant fluid was 




supernatants of purified virus (5X10 pfu/0.1 ml) produced 
a stimulation index of 0.89 in B-enriched cells. Unpurified 
supernatant (2X10 pfu/0.1 ml) actually depressed thymidine 
uptake (stimulation index = 0.76) of B-enriched cells over 
control. Similar results were observed in mixed lympho¬ 
cytes (Table VI). Stimulation assays in which lymphocytes 
were incubated with the supernatant culture fluid (SNF) 
removed from the producer cells (GMK) before inoculation 
3 
with virus produced HTdr uptake essentially identical to 
cultures incubated in RPMI 1640 medium alone (Figure 3). 
Attempts to Isolate Transformed Cell Lines. Limited attempts 
to develop transformed cell lines from umbilical cord lym¬ 
phocytes infected with UV-HSV were conducted in 20% fetal 
calf serum only. Although several of these cultures sur¬ 
vived longer than 60 days, no difference was noted in sur¬ 
vival time or morphology between infected and uninfected 
cultures. No transformed cell lines were isolated. 
Cell Counts of Cultured Lymphocytes Infected with UV-FISV. 
It was important to determine if virus infection affected 
the survival of cells in culture over time, in order to 
interpret stimulation of lymphocytes after 4 days of incu¬ 
bation. Infection with HSV (multiplicity 100:1 pfu/cell) 
was conducted in fresh, mixed umbilical cord lymphocytes 
supplemented with 20% and 0.2% fetal calf serum. Cell 
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counts over days after infection, shown in Figure 3, were 
identical for all groups. Greater than 85% of the cells 
in each group were viable by Trypan Blue exclusion. Separ¬ 
ate experiments with B-enriched populations indicate that 
the loss of 50-60% of the initial mixed inoculum of mixed 
cells in the first 1-2 days is due to the death of T lym¬ 




Infected Centers in Lymphocyte Subpopulations 
Infected with HSV-1. 
Infected Centers/103Ce11s 
Cell Population Pre-Infection Culture Interval 
0-5 Days 6+ Days 
MixedCells 0.6 
B-Enriched Cells - 
Macrophages - 
3 










Comparison of Stimulation by UV-HSV: 
Mixed vs "B" Enriched Leukocytes. 
Stimulation Index * 
UV T i me 
Cell Population 6 ' 10' 01 + Centrifugation** 
Mixed Cells 1 . 60 1 .67 1 .03 
"B" Enriched Cells 1 . 54 2.02 .89 
* Stimulation Index 
^HTdr uptake, infected cells 
3 
HTdr uptake, uninfected cells 
Assay on fourth day after infection of freshly isolated lymphocyte 
Serum: 0.2% fetal calf serum 
Multiplicity of infection: 1:1 pfu/cell 








































































































































































































Summary. These experiments have shown that live HSV-1 
productively infects only a small fraction (1-6/1000) 
of freshly-isolated human umbilical cord lymphocytes. 
Maintaining these cells in culture for 5 days or more is 
associated with a ten-fold increase in productively infected 
cells. Umbilical cord lymphocytes (HUCL) infected with 
UV-irradiated HSV exhibit significant increases in thymi¬ 
dine uptake compared with sham-infected controls, after 
four days in culture. This effect is intensified by the 
use of reduced serum concentration in the incubation medium 
and by the enrichment of the cell population for "B" cells. 
Sucrose gradient purified virus causes the stimulation 
while unpurified stocks to not; producer-cell (GMK) growth 
medium and virus suspensions depleted of virus by centri¬ 
fugation do not cause stimulation; and the virus prepara¬ 
tion itself was shown to be free of cellular debris or myco¬ 
plasma contamination. Maximal stimulation is caused by 
virus exposed to ultraviolet light for 6' to 10' and occurs 
3 to 4 days after infection. 
Association of Lymphocyte Infectivity and Aging in Culture. 
The increase in cells susceptible to infection by HSV over 
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5 to 7 days of i_n vitro culture is similar to the result 
found in macrophages by Daniels et al. The correlation 
with the increase in DNA synthesis in cultures over time 
may suggest that cell cycle and/or metabolism influence 
9 9 7 104 
susceptibility to HSV infection. ’ ’ It is also 
possible that i_n vitro culture selects susceptible cells, 
and loss of certain cells (e.g. "T" cells) in the first 
days after isolation inactivates the infection resistance 
exhibited by the culture when all cell populations are 
represented in i_n v i vo proportions. 
Stimulation of Lymphocytes by UV-HSV. A number of uncer¬ 
tainties about the meaning of the demonstrated increase in 
thymidine uptake persists. 
1) Viral Antigen or Genome as Lymphocyte Stimulator? 
Whether the stimulation is due to antigens on the virus 
surface or due to the viral genome itself has not been 
shown. Howver, the use of lymphocytes presumed to be non- 
immune and washed free of autologous humoral factors suggests 
1 09 
that immune mechanisms do not play a part. Starr pro¬ 
duced a stimulation index of 25 in adult immune lymphocytes 
exposed to heat-inactivated HSV antigens but found no stim¬ 
ulation of umbilical cord lymphocytes. The fact that selec¬ 
tive UV irradiation of virus, a technique known to function 
by damaging viral DNA,^ was required for stimulation in 
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these experiments further supports the notion that the 
partially inactivated genome is responsible. If a surface 
antigen were the stimulatory principle, one might expect 
increasing stimulation with increasing doses of UV, rather 
than the convex curve observed (Figure 3). 
The possibility that a small number of immunized 
maternal cells in the umbilical cord blood are responsible 
for the effect cannot be entirely excluded. Data concern¬ 
ing theextent of maternal cell contamination of human 
12 6 
umbilical cord blood is scant. Sharpe examined the 
metaphases of peripheral lymphocytes in four male neonates 
and found 0.6% of lymphocytes in one infant had a female 
karyotype; he concluded that transplacental lymphocyte 
migration is a rare event. 
1 2 7 
Fujikura surveyed blood from placentas obtained 
after delivery for the presence of sickle cells in the 
offspring of hemoglobin (SS) mothers. He found 8.4% of 
erythrocytes in the umbilical cord vein were sickled, but 
12 8 
Olding found no maternal lymphocytes in fourteen separ¬ 
ate samples of umbilical vein blood collected intrapartum. 
Grogan et al. reported a case of fatal graft-versus-host 
reaction to lymphocytes of maternal origin in a neonate 
1 29 
with severe combined immune deficiency which indicates 
that although rare, transplacental materna1 -feta 1 lympho¬ 




Lawler has suggested that the immune-competant 
fetus may be able to suppress maternal-1ymphocyte activa¬ 
tion. He demonstrated in mixed maternal-HUCL culture 
(1:1) that the ratio of mitoses favored fetal cells 6-8:1. 
1 31 
Even more convincing is the observation by 01 ding that 
98% of the mitoses in maternal/HUCL cultures stimulated 
with phytohemaglutinin were in fetal cells. This work was 
1 32 
confirmed by Adinolfi. 
Thus the possibility that UV-HSV stimulation of 
umbilical cord lymphocytes is anti genically mediated is 
remote. The intensification of stimulation in B-enriched 
and macrophage-depleted cell populations also mitigates 
against an immune phenomenon: HSV is known to be a "T- 
114 133 
dependent" antigen. ’ Oppenheim et al. observed that 
a variety of antigens activated pre-immunized lymphocytes 
but not umbilical cord lymphocytes; in non-immune cells, 
only mitogens (PHA, Con A, anti1ymphocyte globulin) were 
1 34 
capable of causing activation. 
It is possible that UV-inactivated HSV possesses a 
mitogen on its surface. Future experiments to determine 
if stimulation is affected by maternal antibody status or 
the neutralization of HSV by heat or antiserum will help 
clarify this issue. 




of HTdr in UV-HSV exposed cells is considered to be due 
to increased incorporation of thymidine into DNA and, 
therefore, increased DNA synthetic activity. Bain reported 
3 
that uptake of HTdr in mixed adult lymphocyte cultures 
was linear over periods of up to five hours, and that the 
1 35 
incorporation was directly into DNA. He documented the 
3 
formation of numerous degradation products of HTdr, but 
these were not included into acid-inso1ub1e material. 
Whether thymidine incorporation is associated with 
viral or cellular DNA synthesis in these experiments has 
not been determined. Indirect evidence suggest, however, 
that UV-HSV probably stimulates cellular DNA synthesis: 
numerous reports have documented HSV replication in lym¬ 
phocytes over 3-5 days after infection^09 but 
9 7 3 
Rinaldo found no increase in HTdr uptake in infected 
6 6 
cultures versus controls; Yamanishi et al. compared 
3 
HTdr uptake by hamster cells exposed to live and tempera¬ 
ture-mutant HSV and observed stimulation only in the mutant- 
infected cells. 
Future experiments should determine, via cesium 
3 
chloride density gradients, whether the HTdr is incor¬ 
porated into viral or cellular DNA. 
3 




Thymidine incorporation may be involved in the replication 
of DNA (mitogenesis) or in the repair of damaged DNA. 
These experiments have not addressed this issue, but differ¬ 
entiation of these possibilities is important because the 
introduction of UV-damaged viral DNA into the cell may of 
itself stimulate endogenous repair mechanisms for correction 
92 
of defects in the viral genome. Radman has proposed 
that the introduction of damaged viral DNA may provoke an 
"error prone" cellular DNA repair system; during such repair, 
mutagenesis of the cell occurs through incorrectly repaired 
genome sequences. Future experiments to determine if stim¬ 
ulated cultures are undergoing semi-conservative DNA synthe¬ 
sis or repair should help resolve this important question. 
3 
4) Htdr Uptake: Increased DNA Synthesis or Increased 
Thymidine Kinase Activity? 
DNA replication in eukaryotic cells involves the incorpor¬ 
ation of thymidine (as thymidine triphosphate (TTP)), mainly 
derived from the conversion of uridine monophosphate via the 
1 sg 
so-called endogenous pathway. A very small fraction of 
the TTP is derived from pre-formed thymidine; pre-formed 
thymidine enters the DNA synthetic cycle via the "salvage" 
pathway and the enzyme thymidine kinase. Stimulation 
3 
assays utilizing HTdr depend on the salvage pathway to 
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measure thymidine integration into DNA and thus to infer 
relative rates of DNA synthesis. 
Numerous studies cited above^’^’^3 documented the 
transfer of the thymidine kinase (TK) gene from the HSV 
genome to mouse cells lacking that enzyme. It is also 
possible that importation of the TK gene on HSV during 
infection of lymphocytes induces increased activity of this 
3 
enzyme. Increased uptake of HTdr could then occur without 
a net increase in DNA synthesis. 
Arguing against this notion is the report by Starr 
3 
et a 1. that no increased HTdr uptake occurred in HUCL 
1 09 
exposed to heat-inactivated HSV although heat-inactiva¬ 
tion of the TK gene in that experiment cannot be excluded. 
Yamanishi reported a net increase in cellular DNA synthesis 
in hamster cells infected with a termperature-sensitive 
mutant of HSV. However it is important that future work 
be able to show that UV-HSV infected cultures exhibit thy¬ 
midine kinase activity similar to controls and that net 
DNA synthesis is increased. 
5) Effect of Serum Starvation: Reduction of Background 
or Enhanced Susceptibility to HSV? 
Reduction of the serum supplementation in other cell systems 
has had the effect of reducing the background DNA synthesis 
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and repair, and presumably unmasking low-level stimulatory 
effects , ^5^ ^^ this technique has not been applied 
to human leukocytes. In the present studies, counts per 
minute (cpm) of medium-inoculated cultures after four days 
were 30% lower in 0.2% fetal calf serum (FCS) than in 20% 
FCS, although in one experiment no difference was noted. 
By 7 days, activity in the 0.2% FCS cultures was 50% less 
than that of the 20% FCS. It is likely that the lowered 
TOO 
serum concentration "arrested" the cells. Johnson has 
suggested, however, that fetal calf serum contains a mito- 
1 39 
genic substance and Alford et al. reported that lympho¬ 
cyte transformation by mitogens was more efficient when 
autologous serum was added than with heterologous or calf 
serum. 
The last two reports indicate that fetal calf serum 
in the medium may inhibit transformation or at least increase 
the baseline mitogenesis in the culture. It may be that 
the resistance of lymphocytes to infection and transformation 
by HSV is attributable to the metabolic state conferred by 
the fetal calf serum. Further investigation of the varying 
effects of fetal calf serum and autologous serum is warranted. 
Lymphocytes and HSV: Prospects for the Future. 
The basis for the striking resistance of the lymphocyte 
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to infection and transformation by HSV remains unknown. 
It is likely that this resistance transcends the immune 
functions of these cells, for even isolated primary "B" 
lymphocytes are refractory. 
Some of the findings in the present experiments ring 
true to work done in other cell systems: the optimal 
stimulation dose of UV (6' to 10') is very similar to the 
dose used in transforming rodent cells (Table I); the use 
of serum starvation enhanced detectable stimulation although 
the cells remained viable. 6*74,125,137 jhese similarities 
suggest that certain intrinsic properties of the HSV genome 
are unmasked by limited UV damage to the DNA, and that 
damaged virus is capable of interacting with cells, probably 
all cells, in a characteristic fashion which may, in the 
right setting, involve oncogenic transformation. 
Extension of the present findings will require careful 
exclusion of the possibilities of induced TK and DNA-repair 
activity and antigenic interaction with maternal HUCL 
contaminants, as discussed above. Several virus strains 
should be screened for stimulatory ability (cf. Rapp and 
3 8 
Duff's finding of 2/12 transforming strains ). Assays 
conducted over longer term (21 days) may assist in deter¬ 
mining if the stimulation in 0.2% fetal calf serum is 
transitory or the harbinger of transformation of a small 
clone of cells. Finally, if dedicated effort to induce 
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outgrowth of a transformed cell line is successful, these 
cells should be tested for the presence of HSV antibodies 
and/or HSV genomes. 
Further elucidation of the effects documented in this 
paper may prove fruitful in demonstrating new aspects of 
the action of herpesviruses in oncogenesis, and at the 
very least may shed light on the peculiar ability of the 
lymphocyte to abort viral infection and replication. 
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